Rilutek (riluzole) tablets in the U.S.
February 1996
Rhone-Poulenc Rorer is now marketing Rilutek (riluzole) tablets in the U.S...probably soon in Canada.
This is the first drug approved for treating amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
ALS is a progressive, degenerative disease of the nerves. It leads to muscle weakness...paralysis...and eventually death.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote